BeStock  
Stocks › Biotechnology › CLDX

Celldex Therapeutics CLDX

US equityMarket cap rank #2636Biotechnology
$27.42 −$0.54 (-1.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 -0.07%
Open$27.01
Prev close$27.96
Day range$26.64 – $28.43
Volume1.72M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

CLDX Stock News

Headlines matching Celldex Therapeutics or the CLDX ticker, most recent first.

  • LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $64 PositiveMarket news · 28 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $57Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $88Market news · 24 Sep 2026 · Direct mention
  • Leerink Partners Maintains Outperform on Celldex Therapeutics, Raises Price Target to $88 PositiveBenzinga · 23 Sep 2026 · Related
  • Celldex Therapeutics Is Maintained at Overweight by Morgan StanleyDow Jones · 23 Sep 2026 · Related
  • A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $100Market news · 23 Sep 2026 · Direct mention
  • Celldex Therapeutics Is Maintained at Outperform by Leerink Partners PositiveDow Jones · 23 Sep 2026 · Related
  • Celldex Therapeutics Price Target Raised to $88.00/Share From $70.00 by Leerink Partners PositiveDow Jones · 23 Sep 2026 · Related
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeutics (EWTX)TipRanks · 23 Sep 2026 · Direct mention
  • Celldex Therapeutics | 8-K: Current reportSEC · 22 Sep 2026 · Related
  • LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $56Market news · 21 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 10 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $56Market news · 8 Aug 2026 · Direct mention
  • 10-Q: Celldex Therapeutics | 10-Q: Q2 2026 Earnings ReportSEC · 7 Aug 2026 · Related
  • A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $100Market news · 7 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CLDX.

Sign in to join the discussion.

Scroll to Top